Figure 4From: Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiationTreating all sites of metastatic disease with radiation therapy does not result in improved outcomes in Stage IV IBC patients after PMRT. (A) overall survival and (B) progression-free survival.Back to article page